Value-Based Purchasing and Comparative Effectiveness Research

Share this article:
Value-Based Purchasing and Comparative Effectiveness Research
Value-Based Purchasing and Comparative Effectiveness Research
Value-Based Purchasing and Comparative Effectiveness: Why the Pharmaceutical, Biotechnology, and Medical-Surgical Device Industries Should Embrace the Coming Market Evolution

For years, health economics has assisted healthcare stakeholders in making informed evaluations of treatment alternatives. Now, the advent of value-based purchasing (VBP) and comparative effectiveness research (CER) are leading to new methods for identifying products with the highest "value"—those that ideally deliver both overall cost reductions and improved patient health. These trends will increasingly impact the way healthcare products are marketed and sold.

This paper examines the march to VBP and CER evaluations, and makes specific recommendations to manufacturers and brand teams regarding how combining clinical and economic data is essential to the successful marketing of drugs and devices.

Please click here to download this white paper.

About MarCom Group International, Inc.:

MarCom Group International works with US and global pharmaceutical, medical-surgical, and biotechnology companies to provide medical marketing communications, health economics, and physician education services. MarCom's health economics team combines expert research, strategic analytics, and scientific communications for world-class results.

Click here for more information about MarCom Group International, Inc.





How to download the MarCom White Paper:

If you don't have a username and password to mmm-online.com,
  • Click "register here" on the MarCom White Paper download page
  • Enter in your contact information
  • An email will be sent to your email address with a link to confirm your registration
  • Click on the link in your email to sign in your username and new password
  • Download the MarCom White Paper



Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?